Previous Meetings

GBCC 10

Global Breast Cancer Conference 2021

09:00-10:15
Symposium 1
Current Strategies for Hormone Receptor (+) HER2 (-) Breast Cancer
Venue: A
  • Optimal Sequence of Endocrine Therapy in Hormone Receptor (+) MBC
    Shinji Ohno (Cancer Institute Hospital of JFCR, Japan)
  • CDK4/6 Inhibitors: Ideal Application and Resistance Mechanism
    Karen Gelmon (Univ. of British Columbia, Canada)
  • New Therapeutic Options to Overcome Endocrine Resistance
    Ingrid Mayer (Vanderbilt Univ. Medical Center, U.S.A.)
Panel Discussion 1
DCIS: Low to Intermediate Grade vs. High Grade
Venue: D
  • Pathologic Risk Stratification of DCIS
    Gary Tse (The Chinese Univ. of Hong Kong, Hong Kong)
  • Personalizing Treatment Strategies for Low Risk DCIS
    E. Shelley Hwang (Duke Univ. School of Medicine, U.S.A.)
  • De-escalation of Radiotherapy in DCIS
    Icro Meattini (Univ. of Florence, Italy)
Education Session 1
In-depth Discussion for Breast Cancer Screening
Venue: E
  • Risk-based Breast Cancer Screening: Age to Begin and Interval
    Vivian Youngjean Park (Yonsei Univ. College of Medicine, Korea)
  • Screening Mammography: Risk and Safety
    Jin Chung (Ewha Womans Univ. Mokdong Hospital, Korea)
  • AI and the Future of Breast Cancer Detection and Risk Prediction
    Constance Lehman (Harvard Medical School, U.S.A.)
Endoscopic and Robotic Breast Session
Venue: F
  • Robotic LD flap and DIEP
    Jesse C. Selber (MD Anderson Cancer Center, U.S.A.)
  • Breast Reconstruction with Robot-assisted Surgery
    Dong Won Lee (Yonsei Univ. College of Medicine, Korea)
  • Robotic Mastectomy in Korea
    Hyung Seok Park (Severance Hospital, Korea)
GBCC-JBCS Joint Meeting 1
Clinical Trials in JBCS and KBCS
Venue: G
  • Current Situation of Clinical Trials in the Japanese Breast Cancer Society
    Naoki Niikura (Tokai Univ. School of Medicine, Japan)
  • Current Situation of Clinical Trials in the Korean Breast Cancer Society
    Joon Jeong (Gangnam Severance Hospital, Korea)
10:35-11:50
Symposium 2
How to Target HER2 in Breast Cancer Better?
Venue: A
  • Moving Towards
    Yoon-Sim Yap (National Cancer Centre Singapore, Singapore)
  • Fine Tuning of Perioperative HER2 Targeting in Early Stage HER2 (+) Breast Cancer
    Yeon Hee Park (Samsung Medical Center, Korea)
  • Best Combination Strategy of Immunotherapy with Conventional HER2 Targeted Therapy
    Otto Metzger (Dana-Farber Cancer Institute, U.S.A.)
Panel Discussion 2
Overcoming Limitations of Resources in Developing Asian Countries
Venue: D
  • Optimal Application of Standard of Care in Systemic Therapy: Generic, Biosimilar, Cost-effectiveness?
    In Hae Park (Korea Univ. Guro Hospital, Korea)
  • Can We Increase the Rate of Accepting Breast Conserving Surgeries in Countries with Limited Resources?
    Kong Wee Ong (K W Ong Breast & General Surgery, Singapore)
  • Breast Cancer Radiotherapy in Ho Chi Minh City Cancer Hospital
    Thi Tuyet Anh Cung (Ho Chi Minh City Univ. of Medicine and Pharmacy, Viet Nam)
Education Session 2
Advances in Image-guided Breast Intervention
Venue: E
  • Percutaneous Intervention (Needed) for Targeted Axillary Dissection
    Jessica Leung (MD Anderson Cancer Center, U.S.A.)
  • Preoperative Image-guided Breast Intervention (Wire, Tatooing, Marker)
    Eun Young Ko (Samsung Medical Center, Korea)
  • Strategy of Image-guided Intervention in the Diagnosis of Suspicious Microcalcification
    Woo Jung Choi (ASAN Medical Center, Korea)
OPBS Session 1
How to Train Oncoplastic Breast Surgery in Asia
Venue: F
  • How to Establish a Training Center for Oncoplastic and Endo-robotic Breast Surgery
    Benjamin Sarfati (Institut Gustave Roussy, France)
  • Visiting and Training System for Oncoplastic and Endo-robotic Breast Surgery
    Jeeyeon Lee (Kyungpook National Univ. Chilgok Hospital, Korea)
  • Experience of Clinical Oncoplastic Fellowship in Various Countries
    So-Youn Jung (National Cancer Center, Korea)
GBCC-JBCS Joint Meeting 2
Education Program for Young Doctors in Two Countries
Venue: G
  • Program for Young Doctors in KBCS and the Future Direction of Junior Doctors Forum in GBCC (KBCS)
    Han-Byoel Lee (Seoul National Univ. Hospital, Korea)
  • Program for Young Doctors in JBCS
    Norikazu Masuda (National Hospital Organization Osaka National Hospital, Japan)
  • Experience of Education Program in Asia (Japan Team Oncology Program)
    Naoto Ueno (MD Anderson Cancer Center, U.S.A.)
12:10-12:55
Plenary Lecture 1
Venue: A
  • The Molecular Etiology of ER+ Breast Cancer
    Matthew Ellis (Baylor College of Medicine, U.S.A.)
13:10-13:55
Satellite Symposium 1-1
Venue: A
  • Optimal Treatment for HR+/HER2- Metastatic Breast Cancer Patients: CDK 4/6 Inhibitors Based on Real-world Practice
    Giuseppe Curigliano (Univ. of Milan / European Institute of Oncology, Italy)
Satellite Symposium 1-2
Venue: E
  • Optimizing Treatment Sequence with Olaparib in gBRCAm Metastatic Breast Cancer
    Karen Gelmon (Univ. of British Columbia, Canada)
14:10-14:55
Plenary Lecture 2
Venue: A
  • Changing the Trajectory for Premenopausal HR(+) Metastatic Breast Cancer Patients through Clinical Trials: Bridging the Gap between Guidelines and Clinical Practice
    Seock-Ah Im (Seoul National Univ. Hospital, Korea)
15:10-16:25
Panel Discussion 3
The Role of Locoregional Therapy in Advanced Breast Cancer Patients
Venue: D
  • Management of Skin Metastasis and Malignant Wounds
    Junping Shiau (Kaohsiung Medical Univ. Hospital, Taiwan)
  • Radiation Therapy to Primary Tumor in Stage IV Breast Cancer
    Yeon Joo Kim (ASAN Medical Center, Korea)
  • Locoregional Treatment Modalities in Breast Cancer Patients with Oligometastases
    Shigeru Imoto (Kyorin Univ. School of Medicine, Japan)
Education Session 3
Biology of Breast Cancer
Venue: E
  • Clinical Proteomics for Breast Cancer
    Han Suk Ryu (Seoul National Univ. Hospital, Korea)
  • Traditional Yet Important Biomarkers in Breast Cancer: ER, PR, HER2 and Ki-67
    Giuseppe Viale (Univ. of Milan / European Institute of Oncology, Italy)
  • Clinical Molecular Testing for Breast Cancer Management
    Naoto Ueno (MD Anderson Cancer Center, U.S.A.)
OPBS Session 2
Combined Approach for Oncoplastic & Reconstructive Surgery
Venue: F
  • What Is Key Point in Training of Oncoplastic and Endo-robotic Breast Surgery
    Eisuke Fukuma (Kameda Medical Center, Japan)
  • Differences between Surgical Oncologist and Oncoplastic Surgeon
    Visnu Lohsiriwat (Siriraj Hospital, Mahidol Univ., Thailand)
  • Experience of Oncoplastic and Endo-robotic Breast Surgery & International Fellowship Training
    Hung-Wen Lai (Changhua Christian Hospital, Taiwan)
GBCC Sino-Korean Joint Meeting
Medical Treatment and Clinical Trials in Korea and China
Venue: G
  • The New Progress of Medical Therapeutic Treatment and Clinical Trials in Breast Cancer in China
    Qiang Liu (Sun Yat-sen Memorial Hospital, China)
  • The New Progress of Medical Therapeutic Treatment and Clinical Trials in Breast Cancer in Korea
    Hee Kyung Ahn (Gachon Univ. Gil Medical Center, Korea)
16:45-18:00
Panel Discussion 4
Genomic Testing with NGS Panels
Venue: D
  • Application of Genomic Analysis in Clinic: ESMO Recommendation
    Giuseppe Curigliano (Univ. of Milan / European Institute of Oncology, Italy)
  • Issues in Tissue Based NGS Analysis
    Woong-Yang Park (Samsung Medical Center, Korea)
  • Clinical Implementation of Liquid Biopsy Panels
    Sarat Chandarlapaty (Memorial Sloan Kettering Cancer Center, U.S.A.)
Education Session 4
Toxicity Management for Breast Cancer Patients
Venue: E
  • Management of Climacteric Symptoms from Hormone Treatment
    Ava Kwong (The Univ. of Hong Kong, Hong Kong)
  • Assessment and Management of Acute Toxicity of Chemotherapy
    Su-Jin Koh (Ulsan Univ. Hospital, Korea)
  • Detection and Management of Long-term Toxicity of Systemic Treatment: Cardiac Toxicity, Immunotherapy-induced Endocrinopathy, etc.
    Po-Han Lin (National Taiwan Univ. Hospital, Taiwan)
OPBS Session 3
Recent Updates for Surgery and Reconstruction
Venue: F
  • A to Z of Endoscopic Mastectomy
    Eisuke Fukuma (Kameda Medical Center, Japan)
  • Recent Update of Autologous Reconstruction
    Jung Ho Lee (The Catholic Univ. of Korea, Bucheon St. Mary's Hospital, Korea)
  • Recent Update of Implant-based Breast Reconstruction
    Ung-sik Jin (Seoul National Univ. Hospital, Korea)
ABCN Business Meeting (Invited Only)
Venue: G
  • Identifying the Unmet Need: One Step Forward to Practice-Changing Trial
    Seock-Ah Im (Seoul National Univ. Hospital, Korea)
  • Mentorship and International Collaboration
    Giuseppe Curigliano (Univ. of Milan / European Institute of Oncology, Italy)
Back to Previous Meetings